Tanuma S, Yagi T, Johnson G S
Arch Biochem Biophys. 1985 Feb 15;237(1):38-42. doi: 10.1016/0003-9861(85)90251-6.
Endogenous ADP ribosylation of nonhistone high-mobility group (HMG) proteins and histone H1 was studied in cultured mouse mammary tumor cells following treatment with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). MNNG treatment of cells caused a rapid and transient increase in ADP ribosylation of histone H1 and HMG 1 and 2, whereas (ADP-ribose)n on HMG 14 and 17 was not affected. 3-Aminobenzamide, an inhibitor of (ADP-ribose)n synthetase, prevented the increase in ADP ribosylation of histone H1 and HMG 1 and 2. This inhibitor enhanced the cell-killing effect of MNNG, but had no significant effect on the removal of methylated purines. The preferential increase in ADP ribosylation of HMG 1 and 2 and histone H1 may be necessary for cell recovery from DNA damage.
在用N-甲基-N'-硝基-N-亚硝基胍(MNNG)处理后,对培养的小鼠乳腺肿瘤细胞中,非组蛋白高迁移率族(HMG)蛋白和组蛋白H1的内源性ADP核糖基化进行了研究。用MNNG处理细胞会导致组蛋白H1以及HMG 1和2的ADP核糖基化迅速且短暂增加,而HMG 14和17上的(ADP-核糖)n不受影响。(ADP-核糖)n合成酶的抑制剂3-氨基苯甲酰胺可阻止组蛋白H1以及HMG 1和2的ADP核糖基化增加。该抑制剂增强了MNNG的细胞杀伤作用,但对甲基化嘌呤的去除没有显著影响。HMG 1和2以及组蛋白H1的ADP核糖基化优先增加可能是细胞从DNA损伤中恢复所必需的。